(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -61.28%50.89M | -7.98%258.89M | 3.40%131.44M | 54.43%281.33M | 71.88%127.12M | 159.37%182.18M | 64.79%73.96M | -65.41%70.24M | --44.88M | 9.64%203.09M |
Operating income | -61.28%50.89M | -7.98%258.89M | 3.40%131.44M | 54.43%281.33M | 71.88%127.12M | 159.37%182.18M | 64.79%73.96M | -65.41%70.24M | 44.88M | 9.64%203.09M |
Cost of sales | 58.46%-48.88M | 7.28%-239.38M | -2.25%-117.68M | -60.66%-258.18M | -78.83%-115.08M | -169.41%-160.7M | -87.86%-64.36M | 59.44%-59.65M | ---34.26M | -14.10%-147.06M |
Operating expenses | 58.46%-48.88M | 7.28%-239.38M | -2.25%-117.68M | -60.66%-258.18M | -78.83%-115.08M | -169.41%-160.7M | -87.86%-64.36M | 59.44%-59.65M | -34.26M | -14.10%-147.06M |
Gross profit | -85.44%2.01M | -15.71%19.51M | 14.35%13.77M | 7.80%23.15M | 25.34%12.04M | 102.80%21.48M | -9.60%9.6M | -81.10%10.59M | 10.62M | -0.56%56.02M |
Administrative expenses | 10.18%-10.54M | -25.62%-22.05M | -30.11%-11.73M | 9.02%-17.56M | 0.09%-9.02M | -6.03%-19.3M | 2.15%-9.02M | -65.65%-18.2M | ---9.22M | -75.08%-10.99M |
Impairment and provision | -95.06%160K | 70.01%-3.75M | 175.31%3.24M | -62.05%-12.5M | -93.22%-4.3M | -73.40%-7.71M | -3,610.00%-2.23M | -616.26%-4.45M | ---60K | ---621K |
-Other impairment is provision | -95.06%160K | 70.01%-3.75M | 175.31%3.24M | -62.05%-12.5M | -93.22%-4.3M | -73.40%-7.71M | -3,610.00%-2.23M | -616.26%-4.45M | ---60K | ---621K |
Special items of operating profit | 394.26%1.03M | -202.91%-1.63M | -57.00%209K | 90.93%1.58M | 12,050.00%486K | 111.40%827K | 100.06%4K | 57.25%-7.26M | ---7.11M | -949.72%-16.97M |
Operating profit | -233.76%-7.34M | -48.62%-7.91M | 792.55%5.49M | -13.15%-5.33M | 51.74%-792K | 75.63%-4.71M | 71.54%-1.64M | -170.37%-19.31M | -5.77M | -43.36%27.44M |
Financing cost | 3.01%-129K | -9.16%-274K | 15.82%-133K | 0.00%-251K | -119.44%-158K | -161.46%-251K | -24.14%-72K | 38.46%-96K | ---58K | -333.33%-156K |
Earning before tax | -239.50%-7.47M | -46.84%-8.19M | 663.37%5.35M | -12.49%-5.58M | 44.54%-950K | 74.46%-4.96M | 70.58%-1.71M | -171.13%-19.41M | -5.82M | -43.64%27.29M |
Tax | 103.26%28K | 118.84%218K | -78.05%-860K | -8,164.29%-1.16M | -16.95%-483K | 98.26%-14K | 35.47%-413K | 88.52%-806K | ---640K | -1.34%-7.02M |
After-tax profit from continuing operations | -265.58%-7.44M | -18.37%-7.97M | 413.47%4.49M | -35.45%-6.73M | 32.60%-1.43M | 75.41%-4.97M | 67.11%-2.13M | -199.74%-20.22M | -6.46M | -51.15%20.27M |
Earning after tax | -265.58%-7.44M | -18.37%-7.97M | 413.47%4.49M | -35.45%-6.73M | 32.60%-1.43M | 75.41%-4.97M | 67.11%-2.13M | -199.74%-20.22M | -6.46M | -51.15%20.27M |
Profit attributable to shareholders | -265.58%-7.44M | -18.37%-7.97M | 413.47%4.49M | -35.45%-6.73M | 32.60%-1.43M | 75.41%-4.97M | 67.11%-2.13M | -199.74%-20.22M | -6.46M | -51.15%20.27M |
Basic earnings per share | -268.18%-0.0037 | -17.65%-0.004 | 414.29%0.0022 | -36.00%-0.0034 | 36.36%-0.0007 | 75.96%-0.0025 | 67.65%-0.0011 | -177.04%-0.0104 | -0.0034 | -46.00%0.0135 |
Diluted earnings per share | -0.0034 | |||||||||
Currency Unit | HKD | HKD | HKD | HKD | MOP | MOP | MOP | MOP | MOP | MOP |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data